首页|抗糖尿病药物对肌少症影响的研究进展

抗糖尿病药物对肌少症影响的研究进展

扫码查看
肌少症是一种肌肉量减少和(或)肌肉功能下降的疾病,极大地增加了老年人跌倒、骨折甚至死亡的风险.糖尿病可并发肌少症,但其病因及机制尚不明确.而且,2型糖尿病患者使用的抗糖尿病药物,除了抗糖尿病作用外,还可以通过不同的机制作用于骨骼肌,影响蛋白质合成与分解之间的平衡,从而导致肌少症的发生.本文阐述了抗糖尿病药物对肌少症的潜在作用机制,并提供了相关的临床研究和数据.
Exploring the impact of anti-diabetic medications on sarcopenia:a comprehensive review
Sarcopenia is a condition characterized by a reduction in muscle mass and/or diminished muscle function,significantly amplifying the risk of falls,fractures,and even mortality among the elderly.Although diabetes can be further complicated by sarcopenia,the precise cause and mechanism remain unclear.Moreover,the impact of anti-diabetic medications,commonly used by individuals with type 2 diabetes,extends beyond glycemic control.These drugs can influence skeletal muscle through diverse mechanisms,affecting the delicate balance between protein synthesis and breakdown,thereby contributing to the development of sarcopenia.This article delves into the potential mechanisms of anti-diabetic drugs on sarcopenia,offering insights from relevant clinical studies and data.

SarcopeniaAnti-diabetic drugsSkeletal muscleDiabetes

谭莅唐、付颖

展开 >

首都医科大学附属北京潞河医院,北京 101149

首都医科大学附属北京潞河医院内分泌代谢与免疫性疾病中心,北京 101149

糖尿病防治研究北京市重点实验室,北京 101149

肌少症 抗糖尿病药物 骨骼肌 糖尿病

Capital Medical University"Undergraduate Scientific Research Innovation"Project

XSKY2021387

2024

中国药学(英文版)
中国药学会

中国药学(英文版)

CSTPCD
影响因子:0.534
ISSN:1003-1057
年,卷(期):2024.33(6)